May 21, 2013 4:12 AM ET

Capital Markets

Company Overview of Pappas Ventures

Company Overview

Pappas Ventures is a venture capital firm specializing in seed, start-ups, early, mid-stage, and later-stage mezzanine investments. The firm prefers to spend about half of its capital in early-stage companies that have yet to begin testing their products in clinical trials and the other half in companies whose lead products are at the Phase 1 or Phase 2 stage of development. It typically seeks to invest in firms going through Series A and Series B rounds of financing. The firm invests in life science sector with a focus on biotechnology, biopharmaceuticals, specialty pharmaceuticals, drug delivery, medical devices and related ventures. It prefers to invest in North America, deploying about a...

Detailed Description

2520 Meridian Parkway

Suite 400

Durham, NC 27713

United States

Founded in 1994

Phone:

919-998-3300

Fax:

919-998-3301

www.pappasventures.com

Key Executives for Pappas Ventures

Founder and Managing Partner
Age: 64
Managing Partner
Office Manager
Administrative Assistant
Compensation as of Fiscal Year 2012.

Pappas Ventures Key Developments

Pappas Ventures Presents at 2013 BIO International Convention, Apr-23-2013 03:45 PM

Pappas Ventures Presents at 2013 BIO International Convention, Apr-23-2013 03:45 PM. Venue: McCormick Place - Chicago Bulls Room, 2301 S. Lake Shore Drive, Chicago, IL 60616, United States. Speakers: Arthur M. Pappas, Founder and Managing Partner.

Pappas Ventures Presents at BioContactQuebec 2012, Oct-03-2012 02:00 PM

Pappas Ventures Presents at BioContactQuebec 2012, Oct-03-2012 02:00 PM. Venue: Château Laurier, Quebec City, Quebec, Canada. Speakers: Arthur M. Pappas, Founder and Managing Partner.

Pappas Ventures Names L. Patrick (Pat) Gage to Scientific Advisory Board

Pappas Ventures announced the appointment of L. Patrick (Pat) Gage to the company's Scientific Advisory Board. Dr. Gage has extensive experience in the biotech and pharmaceutical industry, including previously-held senior positions at Hoffmann-La Roche, Genetics Institute and Wyeth (now Pfizer). Throughout his career, he oversaw the development of more than a dozen marketed biologics and vaccines, as well as several small molecule drugs. During his 18-year career at Hoffmann-La Roche, Dr. Gage held several leadership roles in research management, including service as Vice President of Exploratory Research.

Similar Private Companies By Industry

Company Name Region
Concorde Group, Inc. United States
Jay Newlin Trust United States
Indiana Securities, LLC United States
El Paso Area Teachers Federal Credit Union, Inc. United States
Portland Credit Union United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 8, 2013
Lumena Pharmaceuticals, Inc.
Private Placement
December 18, 2012
Ultragenyx Pharmaceutical Inc.
Private Placement
October 25, 2012
Thrasos Innovation Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Greater Houston Partnership United States

Post a JobJobs


    We are currently experiencing technical difficulties. Please try again later.
View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pappas Ventures, please visit www.pappasventures.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.